Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1138

1.

Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).

Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD; Southern California HIV/Eye Consortium.

Am J Ophthalmol. 2008 Jan;145(1):12-22.

PMID:
18154751
2.

Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.

Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.

Ophthalmology. 2000 May;107(5):877-81; discussion 881-3.

PMID:
10811078
3.
4.
5.
6.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team.

AIDS. 2001 Jan 5;15(1):23-31.

PMID:
11192865
8.

Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.

Song MK, Schrier RD, Smith IL, Plummer DJ, Freeman WR.

Retina. 2002 Jun;22(3):262-7.

PMID:
12055457
9.

Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.

Cassoux N, Lumbroso L, Bodaghi B, Zazoun L, Katlama C, LeHoang P.

Br J Ophthalmol. 1999 Jan;83(1):47-9.

10.
11.
12.

The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.

Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA; Studies of Ocular Complications of AIDS Researh Group.

Ophthalmology. 2003 May;110(5):987-95.

PMID:
12750102
13.

Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994).

Holland GN, Vaudaux JD, Jeng SM, Yu F, Goldenberg DT, Folz IC, Cumberland WG, McCannel CA, Helm CJ, Hardy WD; UCLA CMV Retinitis Study Group.

Am J Ophthalmol. 2008 Jan;145(1):5-11.

PMID:
18154750
14.

Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy.

Doan S, Cochereau I, Guvenisik N, Diraison MC, Mousalatti H, Thanh HX.

Am J Ophthalmol. 1999 Aug;128(2):250-1.

PMID:
10458193
15.

CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.

Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.

AIDS. 2000 Jan 28;14(2):173-80.

PMID:
10708288
16.

Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.

Gerna G, Piccinini G, Genini E, Percivalle E, Zavattoni M, Lilleri D, Testa L, Comolli G, Maserati R, Baldanti F, Maccario R, Monforte AD, Revello MG.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):320-31.

PMID:
11707667
17.

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.

Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM.

Nat Med. 1998 Aug;4(8):953-6.

PMID:
9701250
18.

Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.

Robinson MR, Reed G, Csaky KG, Polis MA, Whitcup SM.

Am J Ophthalmol. 2000 Jul;130(1):49-56.

PMID:
11004259
19.
20.

Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Arantes TE, Garcia CR, Saraceno JJ, Muccioli C.

Arq Bras Oftalmol. 2010 Jan-Feb;73(1):16-21.

Items per page

Supplemental Content

Write to the Help Desk